BioLife Solutions, Inc. (BLFS) Announces Quarterly Earnings Results
BioLife Solutions, Inc. (NASDAQ:BLFS) released its quarterly earnings results on Thursday. The medical equipment provider reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.03, Bloomberg Earnings reports. The company had revenue of $2.96 million during the quarter, compared to the consensus estimate of $2.60 million. BioLife Solutions had a negative return on equity of 64.98% and a negative net margin of 63.71%.
BioLife Solutions (BLFS) traded up $0.50 during trading on Friday, reaching $5.65. The company’s stock had a trading volume of 146,537 shares, compared to its average volume of 105,188. BioLife Solutions has a one year low of $1.50 and a one year high of $7.53.
Separately, Maxim Group raised their price target on BioLife Solutions from $7.00 to $8.00 and gave the stock a “buy” rating in a research report on Friday.
BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.
Receive News & Stock Ratings for BioLife Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions Inc. and related stocks with our FREE daily email newsletter.